The paper reflects current, evolving data, an expert says.
Researchers in Portugal have identified 16 patients from a previously unnoticed hospital outbreak with carbapenemase-producing and MCR-1-producing Klebsiella pneumoniae, according to a case report yesterday in Emerging Infectious Diseases.
At least 20% of all primary care antibiotics could be classified as inappropriate.
A study today in Science Translational Medicine describes a new approach to determining the modes of action underlying antimicrobial compounds that could help speed the process of discovering novel antibiotics.
CARB-X, a public-private collaboration that supports companies in early-stage antibiotic discovery and development, recently announced its first funding award for 2018 and provided details about two funding rounds for the current year.
The AMR Industry Alliance says more commitment and funding are needed.
Researchers identify more than 80 genes that contribute to resistance.
A review finds the biomarker cut mortality and antibiotic exposure in patients with acute respiratory infections.
Recommendations focus on public-private R&D funding, incentives, and other steps.
The fast, automated assay performs well against gold standard TB tests.
